# amcure

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/amcure

- Industry: Healthcare Specialists
- Headquarters: Germany
- Website: http://www.amcure.com
- Total disclosed funding: $13M
- Latest round: Series B (Dec 7, 2016)
- Investors on record: 7

## About

amcure GmbH is a German company focused on developing innovative digital health solutions that enhance patient care and improve health outcomes through effective monitoring and data-driven clinical decisions.Founded in 2011 and headquartered in Germany, amcure GmbH specializes in digital health tools aimed at improving healthcare delivery. The company has successfully completed 3 deals, with the most recent funding round being a GRANT in August 2017, where it raised EUR 1.75 mn from the German Federal Ministry of Education and Research. Overall, the company has raised a total of EUR 6.00 mn since inception. The CEO is Klaus Dembowsky.amcure GmbH focuses on innovative healthcare solutions, offering a range of digital health tools designed for healthcare providers and patients. Their products streamline patient monitoring and facilitate data-driven decisions, integrating smoothly with existing systems. These solutions cater to hospitals, private practices, and patients across North America and Europe, allowing for real-time data sharing and improved communication between caregivers and patients.The company's revenue model relies on subscription services for healthcare providers using its digital health solutions. Clients typically engage in tiered subscription contracts, with costs based on service levels and user numbers. This model supports both B2B relationships with healthcare organizations and direct-to-consumer offerings, providing patients with independent access to relevant features. Regular contract renewals and service expansions contribute to a consistent income stream for the company.amcure GmbH plans to leverage its recent funding from August 2017, amounting to EUR 1.75 mn, to support the development and launch of new digital health products. The company aims to expand into additional markets across North America and Europe by 2025, enhancing its service offerings. The funding will be utilized to accelerate product design and facilitate entry into these new geographic regions.

## Funding rounds

- Series B, Dec 7, 2016, $6.3M — KfW Banking Group, LBBW Venture Capital, MBG Schleswig-Holstein, S-Kap Beteiligungskapital, Bregua Corporation, Karlsruhe Institute of Technology
- Series A, Jun 17, 2014, $6.8M — BioM, KfW Banking Group, LBBW Venture Capital, MBG Schleswig-Holstein, S-Kap Beteiligungskapital, Bregua Corporation

## Investors

- BioM (https://capitalatlas.ai/funds/biom) — Series A
- KfW Banking Group — Series A, Series B
- LBBW Venture Capital (https://capitalatlas.ai/funds/lbbw-venture-capital) — Series A, Series B
- MBG Schleswig-Holstein (https://capitalatlas.ai/funds/mbg-schleswig-holstein) — Series A, Series B
- S-Kap Beteiligungskapital (https://capitalatlas.ai/funds/s-kap-beteiligungskapital) — Series A, Series B
- Bregua Corporation — Series A, Series B
- Karlsruhe Institute of Technology — Series B